Literature DB >> 29407133

Incomplete revascularization and long-term survival after coronary artery bypass surgery.

Umberto Benedetto1, Mario Gaudino2, Antonino Di Franco3, Massimo Caputo1, Lucas B Ohmes3, Juan Grau4, David Glineur4, Leonard N Girardi3, Gianni D Angelini1.   

Abstract

BACKGROUND: We sought to investigate the impact of incomplete revascularization (IR) on long-term survival after isolated coronary artery bypass grafting (CABG). The possible interaction between IR and off-pump surgery was also explored.
METHODS: A total of 13,701 patients with multivessel disease undergoing CABG were included in the analysis. All patients received left internal thoracic artery (LITA) to the left anterior descending artery (LAD) territory. IR was defined as at least one diseased arterial territory (right coronary artery [RCA] and/or circumflex [CX] artery) incompletely revascularized.
RESULTS: Overall, 3107 (22.7%) patients received IR. After propensity score matching, IR did not increase all-cause death in the overall group (HR 1.09; 95%CI 0.96-1.22; P=0.17). However, when both RCA and CX artery were incompletely revascularized, late survival was significantly lower (HR 2.15; 95%CI 1.57-2.93). IR was associated with a higher risk of death after off-pump (HR 1.26; 95%CI 1.05-1.49) regardless the extent of IR. After on-pump, IR significantly affected survival only when both RCA and CX artery only were incompletely revascularized (HR 2.32; 95%CI 1.27-4.22).
CONCLUSIONS: The present analysis shows that in patients with LITA-LAD graft the impact of IR on survival is marginal when only one coronary territory is left ungrafted. When both the RCA and CX territory remain unrevascularized the survival rate is significantly reduced. IR after off-pump CABG is associated with significantly lower survival and affects long-term outcome even when only one coronary territory is not revascularized.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CABG; Incomplete revascularization; Off-pump surgery

Mesh:

Year:  2018        PMID: 29407133     DOI: 10.1016/j.ijcard.2017.08.005

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? -a review of the evidences on coronary artery disease.

Authors:  Cristiano Spadaccio; Umberto Benedetto
Journal:  Ann Cardiothorac Surg       Date:  2018-07

2.  Early and Medium Outcomes of On-Pump Beating-Heart versus Off-Pump CABG in Patients with Moderate Left Ventricular Dysfunction.

Authors:  Weitie Wang; Yong Wang; Hulin Piao; Bo Li; Tiance Wang; Dan Li; Zhicheng Zhu; Rihao Xu; Kexiang Liu
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

Review 3.  The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization.

Authors:  Cristiano Spadaccio; Antonio Nenna; David Rose; Francesco Piccirillo; Annunziata Nusca; Francesco Grigioni; Massimo Chello; Gus J Vlahakes
Journal:  J Cardiovasc Transl Res       Date:  2022-03-31       Impact factor: 4.132

4.  Impacts of incomplete revascularization following off-pump coronary artery bypass grafting on clinical outcomes of patients with triple-vessel lesions: insights from a single-center study of propensity-matched data.

Authors:  Qiang Ji; Yun Zhao; Kai Zhu; Kai Song; Jinqiang Shen; Yulin Wang; Ye Yang; Wenjun Ding; Limin Xia; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

5.  Off-pump coronary artery bypass surgery with bilateral internal thoracic arteries: the Leipzig experience.

Authors:  Piroze M Davierwala; Sergey Leontyev; Jens Garbade; Sven Lehmann; David Holzhey; Martin Misfeld; Michael A Borger
Journal:  Ann Cardiothorac Surg       Date:  2018-07

6.  On-Pump vs Off-Pump coronary artery bypass surgery in atrial fibrillation. Analysis from the polish national registry of cardiac surgery procedures (KROK).

Authors:  Mariusz Kowalewski; Marek Jasiński; Jakub Staromłyński; Marian Zembala; Kazimierz Widenka; Mirosław Brykczyński; Jacek Skiba; Michał Zembala; Krzysztof Bartuś; Tomasz Hirnle; Inga Dziembowska; Piotr Knapik; Zdzisław Tobota; Bohdan Maruszewski; Piotr Suwalski
Journal:  PLoS One       Date:  2020-04-22       Impact factor: 3.240

7.  Mid-term outcomes of off-pump versus on-pump coronary artery bypass graft surgery; statistical challenges in comparison.

Authors:  Ali Sheikhy; Aida Fallahzadeh; Saeed Sadeghian; Khalil Forouzannia; Jamshid Bagheri; Abbas Salehi-Omran; Masih Tajdini; Arash Jalali; Mina Pashang; Kaveh Hosseini
Journal:  BMC Cardiovasc Disord       Date:  2021-08-28       Impact factor: 2.298

8.  Long-term survival following postoperative myocardial infraction after coronary artery bypass surgery.

Authors:  Radosław Litwinowicz; Piotr Mazur; Piotr Śliwiński; Magdalena Bryndza; Krzysztof Bartuś; Grzegorz Filip; Artur Bartoszcze; Jacek Piątek; Janusz Konstanty-Kalandyk; Mariusz Kowalewski; Krithika Ramaprabhu; Hubert Hymczak; Bogusław Kapelak; Anna Kędziora
Journal:  J Thorac Dis       Date:  2022-01       Impact factor: 3.005

Review 9.  Off-Pump Coronary Artery Bypass Grafting: 30 Years of Debate.

Authors:  Mario Gaudino; Gianni D Angelini; Charalambos Antoniades; Faisal Bakaeen; Umberto Benedetto; Antonio M Calafiore; Antonino Di Franco; Michele Di Mauro; Stephen E Fremes; Leonard N Girardi; David Glineur; Juan Grau; Guo-Wei He; Carlo Patrono; John D Puskas; Marc Ruel; Thomas A Schwann; Derrick Y Tam; James Tatoulis; Robert Tranbaugh; Michael Vallely; Marco A Zenati; Michael Mack; David P Taggart
Journal:  J Am Heart Assoc       Date:  2018-08-21       Impact factor: 5.501

10.  Long-Term Survival Following Surgical Ablation for Atrial Fibrillation Concomitant to Isolated and Combined Coronary Artery Bypass Surgery-Analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK).

Authors:  Mariusz Kowalewski; Marek Jasiński; Jakub Staromłyński; Marian Zembala; Kazimierz Widenka; Michał Oskar Zembala; Krzysztof Bartuś; Tomasz Hirnle; Inga Dziembowska; Piotr Knapik; Marek Deja; Waldemar Wierzba; Zdzisław Tobota; Bohdan J Maruszewski; Piotr Suwalski
Journal:  J Clin Med       Date:  2020-05-04       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.